Ayahuasca-Assisted Therapy For Addiction: Results From a Preliminary Observational Study in Canada.(2013) Thomas, Lucas, Capler, Tupper, Martin. CDAR
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. (2012) Philippe Lucas, Amanda Reiman, Mitch Earleywine, Stephanie K. McGowan, Megan Oleson, Michael P. Coward, & Brian Thomas. Addiction Research and Theory 1–8
Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain. (2012) Philippe Lucas M.A. Journal of Psychoactive Drugs, 44:2, 125-133
It Can’t Hurt to Ask; A Patient-Centered Quality of Service Assessment of Health Canada’s Medical Cannabis Policy and Program. (2012) Philippe Lucas. Harm Reduction Journal 9:2
A ‘standard joint’? The role of quantity in predicting cannabis-related problems. (2011) Zeisser, Lucas et al
Patient-centered strategies to counter stigma, oppression and forced incarceration in the C/S/X and medical cannabis movements. (2010) Philippe Lucas. Interface; A Journal For and About Social Movements. 2 (2): 149 – 167
Moral regulation and the presumption of guilt in Health Canada’s medical cannabis policy and practice. (2009) Philippe Lucas. International Journal of Drug Policy 20 296–303
Regulating compassion: an overview of Canada’s federal medical cannabis policy and practice. (2008) Philippe G Lucas. Harm Reduction Journal, 5:5
Canadian Public Opinion on Cannabis; How Far Out of Step Is It With The Existing Law? (2007) Andrew D. Hathatway, Patricia G. Erickson & Philippe Lucas. Canadian Review of Social Policy.
Survey of medicinal cannabis use among childbearing women: Patterns of its use in pregnancy and retroactive self-assessment of its efficacy against ‘morning sickness’. (2006) Rachel E. Westfall, Patricia A. Janssen, Philippe Lucas, Rielle Capler. Complementary Therapies in Clinical Practice. 12, 27–33
Like this:
Like Loading...
Leave a Reply